Isothiazolopyrimidines--new group of anticancer agents. I

Arch Immunol Ther Exp (Warsz). 1987;35(5):599-607.

Abstract

Synthesis and biological properties of 27 derivatives of 5-amino-3-methylisothiazolo[5,4-d]pyrimidine-4-dione and of 3-methyl-5-semicarbazido-4-isothiazolocarboxylic acid ethyl esters are discussed. 5-Amino-3-methylisothiazolo[5,4-d]pyrimidine-4-dione was converted by reaction with aldehydes into Schiff bases, which under reduction of NaBH4, were transformed into appropriate N-methylene analogs. 3-Methyl-5-semicarbazido-4-isothiazolocarboxylic acid ethyl esters in reaction with aldehydes were converted into benzylidene derivatives. Some of the compounds obtained, especially those of Schiff base structure, displayed strong activity against L-1210 leukemia, Sa-180 sarcoma. Ehrlich carcinoma and Nemeth Kellner lymphoma.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Ehrlich Tumor / drug therapy
  • Carcinoma, Ehrlich Tumor / pathology
  • Cell Division / drug effects
  • Chemical Phenomena
  • Chemistry
  • Drug Screening Assays, Antitumor
  • Leukemia L1210 / drug therapy
  • Leukemia L1210 / pathology
  • Lymphoma / drug therapy
  • Lymphoma / pathology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Neoplasms, Experimental / drug therapy*
  • Neoplasms, Experimental / pathology
  • Pyrimidines / chemical synthesis
  • Pyrimidines / therapeutic use*
  • Sarcoma, Experimental / drug therapy
  • Sarcoma, Experimental / pathology
  • Thiazoles / chemical synthesis
  • Thiazoles / therapeutic use*

Substances

  • Antineoplastic Agents
  • Pyrimidines
  • Thiazoles